With infections of COVID-19 on the rise, Health Canada has announced that it received its first submission for authorization of a potential vaccine on Thursday.
The vaccine has been developed collaboratively by AstraZeneca and Oxford University.
According to Health Canada, a rolling review of AstraZeneca’s vaccine data will be done in order to assure that the vaccine meets the department’s meticulous safety and efficacy standards.
“The Department will not make a decision on whether to authorize this or any other vaccine until it has received the necessary evidence to support its safety, efficacy and quality,” said Health Canada.
After every vaccine submission is authorized, Health Canada has said it will publish the evidence it reviewed in making its decision, for transparency.
Today, Health Canada received its first submission for authorization for a #COVID19 vaccine. The Department will be reviewing the company’s data to make sure it meets our high standards for safety, efficacy and quality. https://t.co/kmkfWuccS4 pic.twitter.com/o7A5bdREmz
— Health Canada and PHAC (@GovCanHealth) October 2, 2020
Earlier this month, Prime Minister Trudeau announced that Canada had signed an agreement with AstraZeneca to purchase 20 million doses of its COVID-19 vaccine, seeing that it had successfully completed the necessary clinical trials, and was authorized by Health Canada officials.